Ed Arce
Stock Analyst at Westpark Capital
(4.86)
# 382
Out of 5,088 analysts
1034
Total ratings
48.8%
Success rate
23%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ed Arce
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VERU Veru Inc. | Initiated Coverage: Buy | $28 | $2.23 | +1,155.61% | 1 | Oct 6, 2026 | |
| AKBA Akebia Therapeutics | Initiated Coverage: Buy | $7.5 → $4.5 | $0.7422 | +506.31% | 86 | Sep 8, 2026 | |
| TLPH Talphera | Initiated Coverage: Buy | $6 → $3 | $1.07 | +180.37% | 88 | Apr 30, 2026 | |
| MTVA MetaVia | Reiterated: Buy | $132 | $1.19 | n/a | 9 | Sep 17, 2025 | |
| ARCT Arcturus Therapeutics Holdings | Reiterated: Buy | $60 | $12.15 | n/a | 72 | Apr 11, 2025 | |
| UNCY Unicycive Therapeutics | Reiterated: Buy | $75 | $3.81 | n/a | 33 | Apr 11, 2025 | |
| IVA Inventiva | Reiterated: Buy | $13 | $3.73 | n/a | 32 | Apr 3, 2025 | |
| GALT Galectin Therapeutics | Reiterated: Hold | n/a | $3.52 | n/a | 56 | Apr 2, 2025 | |
| ALGS Aligos Therapeutics | Reiterated: Buy | $70 | $5.03 | n/a | 6 | Mar 31, 2025 | |
| ASMB Assembly Biosciences | Reiterated: Hold | n/a | $20.86 | n/a | 30 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $240 | $1.07 | n/a | 21 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.86 | n/a | 36 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $10.43 | n/a | 10 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $400 → $405 | $431.70 | n/a | 42 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $66 → $72 | $86.39 | n/a | 60 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5.5 | $3.10 | n/a | 13 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 | $16.78 | n/a | 10 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $11.15 | n/a | 16 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $4.28 | n/a | 37 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $20.76 | n/a | 2 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $22 | $50.57 | n/a | 26 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.000001 | n/a | 44 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $17.21 | n/a | 90 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.05 | n/a | 12 | Apr 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 | $0.001 | n/a | 7 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $30.53 | n/a | 12 | Jan 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 51 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $16.20 | n/a | 13 | Dec 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.38 | n/a | 33 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $11.40 | n/a | 3 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €12.00 | €3.35 | n/a | 15 | Mar 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 → $31 | $24.03 | n/a | 11 | Feb 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.1577 | n/a | 5 | Nov 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 | $1.11 | n/a | 5 | Aug 12, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.25 | $0.0111 | n/a | 14 | Mar 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $7 | $26.86 | n/a | 2 | Nov 28, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.4246 | n/a | 8 | Nov 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.000001 | n/a | 1 | Jan 30, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $8.52 | n/a | 12 | Jan 26, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7.5 → $5 | $0.0002 | n/a | 8 | Jan 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $0.5 | $0.0008 | n/a | 2 | Mar 19, 2013 |
Veru Inc.
Oct 6, 2026
Initiated Coverage: Buy
Price Target: $28
Current: $2.23
Upside: +1,155.61%
Akebia Therapeutics
Sep 8, 2026
Initiated Coverage: Buy
Price Target: $7.5 → $4.5
Current: $0.7422
Upside: +506.31%
Talphera
Apr 30, 2026
Initiated Coverage: Buy
Price Target: $6 → $3
Current: $1.07
Upside: +180.37%
MetaVia
Sep 17, 2025
Reiterated: Buy
Price Target: $132
Current: $1.19
Upside: n/a
Arcturus Therapeutics Holdings
Apr 11, 2025
Reiterated: Buy
Price Target: $60
Current: $12.15
Upside: n/a
Unicycive Therapeutics
Apr 11, 2025
Reiterated: Buy
Price Target: $75
Current: $3.81
Upside: n/a
Inventiva
Apr 3, 2025
Reiterated: Buy
Price Target: $13
Current: $3.73
Upside: n/a
Galectin Therapeutics
Apr 2, 2025
Reiterated: Hold
Price Target: n/a
Current: $3.52
Upside: n/a
Aligos Therapeutics
Mar 31, 2025
Reiterated: Buy
Price Target: $70
Current: $5.03
Upside: n/a
Assembly Biosciences
Mar 21, 2025
Reiterated: Hold
Price Target: n/a
Current: $20.86
Upside: n/a
Mar 20, 2025
Reiterated: Buy
Price Target: $240
Current: $1.07
Upside: n/a
Mar 18, 2025
Reiterated: Hold
Price Target: n/a
Current: $0.86
Upside: n/a
Mar 11, 2025
Reiterated: Buy
Price Target: $32
Current: $10.43
Upside: n/a
Feb 27, 2025
Reiterated: Buy
Price Target: $400 → $405
Current: $431.70
Upside: n/a
Feb 27, 2025
Reiterated: Buy
Price Target: $66 → $72
Current: $86.39
Upside: n/a
Feb 20, 2025
Reiterated: Hold
Price Target: $5.5
Current: $3.10
Upside: n/a
Feb 18, 2025
Reiterated: Buy
Price Target: $95
Current: $16.78
Upside: n/a
Feb 10, 2025
Reiterated: Buy
Price Target: $18
Current: $11.15
Upside: n/a
Jan 21, 2025
Reiterated: Buy
Price Target: $5
Current: $4.28
Upside: n/a
Jan 14, 2025
Reiterated: Buy
Price Target: $48
Current: $20.76
Upside: n/a
Jan 14, 2025
Reiterated: Buy
Price Target: $18 → $22
Current: $50.57
Upside: n/a
Sep 10, 2024
Reiterated: Buy
Price Target: $5
Current: $0.000001
Upside: n/a
Sep 5, 2024
Reiterated: Buy
Price Target: $13
Current: $17.21
Upside: n/a
Apr 24, 2024
Rated: Hold
Price Target: n/a
Current: $1.05
Upside: n/a
Mar 26, 2024
Reiterated: Buy
Price Target: $120
Current: $0.001
Upside: n/a
Jan 25, 2024
Reiterated: Buy
Price Target: $25
Current: $30.53
Upside: n/a
Mar 27, 2023
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Dec 21, 2021
Reiterated: Hold
Price Target: n/a
Current: $16.20
Upside: n/a
Nov 29, 2021
Reiterated: Hold
Price Target: n/a
Current: $0.38
Upside: n/a
May 12, 2020
Downgraded: Hold
Price Target: n/a
Current: $11.40
Upside: n/a
Mar 18, 2020
Reiterated: Buy
Price Target: €12.00
Current: €3.35
Upside: n/a
Feb 7, 2020
Reiterated: Buy
Price Target: $29 → $31
Current: $24.03
Upside: n/a
Nov 11, 2019
Reiterated: Hold
Price Target: n/a
Current: $0.1577
Upside: n/a
Aug 12, 2019
Reiterated: Buy
Price Target: $27
Current: $1.11
Upside: n/a
Mar 14, 2019
Reiterated: Hold
Price Target: $1.25
Current: $0.0111
Upside: n/a
Nov 28, 2017
Rated: Buy
Price Target: $7
Current: $26.86
Upside: n/a
Nov 6, 2017
Reiterated: Hold
Price Target: n/a
Current: $0.4246
Upside: n/a
Jan 30, 2015
Reiterated: Buy
Price Target: $5
Current: $0.000001
Upside: n/a
Jan 26, 2015
Reiterated: Buy
Price Target: $20
Current: $8.52
Upside: n/a
Jan 9, 2015
Reiterated: Buy
Price Target: $7.5 → $5
Current: $0.0002
Upside: n/a
Mar 19, 2013
Downgraded: Sell
Price Target: $0.5
Current: $0.0008
Upside: n/a